3-bromo-1H-indole-7-amine | 1084328-82-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-bromo-1H-indole-7-amine
• 英文别名: 3-Bromo-1H-indol-7-amine
• CAS: 1084328-82-4
• 化学式: C₈H₇BrN₂
• 分子量: 211.061
• InChiKey: AOTCBNORDMIMEB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.8
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-bromo-1H-indole-7-amine 在 硫酸 、 potassium iodide 、 sodium nitrite 作用下， 反应 0.5h， 以68%的产率得到3-bromo-7-iodo-1H-indole
  参考文献：
  名称：

  유기 전기 발광 소자용 발광 재료, 이를 이용한 유기 전기 발광 소자 및 유기 전기 발광 소자용 재료

  摘要：

  发光波长调节和发光效率优异的融合化合物，以及其制备方法和包含所述融合化合物的有机电子器件。

  公开号：

  KR102175379B1
• 作为产物：
  描述：

  1-BOC-3-溴-7-硝基吲哚 在 铁粉 、 氯化铵 作用下， 以 乙醇 、 水 为溶剂， 以77 %的产率得到3-bromo-1H-indole-7-amine
  参考文献：
  名称：

  [EN] ROCK INHIBITORS AND USES THEREOF
  [FR] INHIBITEURS DE ROCK ET LEURS UTILISATIONS

  摘要：

  本文公开了可用作 ROCK 抑制剂的式 (I) 化合物及其药学上可接受的盐。还公开了包含式（I）化合物的药物组合物，以及使用此类化合物或组合物治疗 ROCK 相关疾病（如青光眼）的方法。

  公开号：

  WO2023226965A1

文献信息

• Design, Structure−Activity Relationships, X-ray Crystal Structure, and Energetic Contributions of a Critical P1 Pharmacophore: 3-Chloroindole-7-yl-Based Factor Xa Inhibitors
  作者：Yan Shi、Doree Sitkoff、Jing Zhang、Herbert E. Klei、Kevin Kish、Eddie C.-K. Liu、Karen S. Hartl、Steve M. Seiler、Ming Chang、Christine Huang、Sonia Youssef、Thomas E. Steinbacher、William A. Schumacher、Nyeemah Grazier、Andrew Pudzianowski、Atsu Apedo、Lorell Discenza、Joseph Yanchunas、Philip D. Stein、Karnail S. Atwal

  DOI：10.1021/jm800855x

  日期：2008.12.11

  An indole-based P1 moiety was incorporated into a previously established factor Xa inhibitor series. The indole group was designed to hydrogen-bond with the carbonyl of Gly218, while its 3-methyl or 3-chloro substituent was intended to interact with Tyr228. These interactions were subsequently observed in the X-ray crystal structure of compound 18. SAR studies led to the identification of compound 20 as the most potent FXa inhibitor in this series (IC(50) = 2.4 nM, EC(2xPT) = 1.2 microM). An in-depth energetic analysis suggests that the increased binding energy of 3-chloroindole-versus 3-methylindole-containing compounds in this series is due primarily to (a) the more hydrophobic nature of chloro- versus methyl-containing compounds and (b) an increased interaction of 3-chloroindole versus 3-methylindole with Gly218 backbone. The stronger hydrophobicity of chloro- versus methyl-substituted aromatics may partly explain the general preference for chloro- versus methyl-substituted P1 groups in FXa, which extends beyond the current series.
• 유기 전기 발광 소자용 발광 재료, 이를 이용한 유기 전기 발광 소자 및 유기 전기 발광 소자용 재료
  申请人：CHOI,DON-SOO 최돈수(419990450773)

  公开号：KR102175379B1

  公开（公告）日：2020-11-09

  발광 파장 조절 및 발광 효율이 우수한 퓨즈드 화합물, 그의 제조방법 및 상기 퓨즈드 화합물을 포함하는 유기전자소자를 제시한다.

  发光波长调节和发光效率优异的融合化合物，以及其制备方法和包含所述融合化合物的有机电子器件。
• [EN] ROCK INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE ROCK ET LEURS UTILISATIONS
  申请人：DIZAL JIANGSU PHARMACEUTICAL CO LTD

  公开号：WO2023226965A1

  公开（公告）日：2023-11-30

  Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as ROCK inhibitors. Also disclosed are pharmaceutical compositions comprising a compound of Formula (I), and methods of using such compounds or compositions to treat ROCK-related disorder (e.g., glaucoma).

  本文公开了可用作 ROCK 抑制剂的式 (I) 化合物及其药学上可接受的盐。还公开了包含式（I）化合物的药物组合物，以及使用此类化合物或组合物治疗 ROCK 相关疾病（如青光眼）的方法。